Regulation

Filter

Current filters:

None

Popular Filters

2576 to 2600 of 2631 results

USA’s CMS to cover infusion costs associated with Dendreon’s Provenge

21-11-2011

Sales of Dendreon’s (Nasdaq: DNDN) new prostate cancer treatment Provenge (sipuleucel-T) have been…

BiotechnologyDendreonNorth AmericaOncologyPharmaceuticalPricingProvengeRegulation

Turkish Pharma and Health Ministry defend clinical trials record

21-11-2011

The Turkish Ministry of Health and the country’s Association of Research-Based Pharmaceutical Companies…

EuropePharmaceuticalRegulationResearch

US FDA revokes Roche/Genentech Avastin license for metastatic breast cancer

21-11-2011

After months of deliberations, the US Food and Drug Administration (FDA Commissioner is revoking the…

AvastinBiotechnologyGenentechNorth AmericaOncologyPharmaceuticalRegulationRoche

Bipartisan bill introduced in USA to increase penalties for counterfeit drugs

21-11-2011

Bipartisan, bicameral legislation was introduced in the USA last week by Senators Patrick Leahy (Democrat,…

HealthcareLegalNorth AmericaPharmaceuticalRegulation

FDA approves Regeneron’s Eylea for wet age-related macular degeneration

21-11-2011

Following unanimous advisory panel support for the drug, the US Food and Drug Administration has approved…

BayerBiotechnologyEyleaNorth AmericaOphthalmicsPharmaceuticalRegeneronRegulation

EMA says bleeding risks associated with Boehringer Ingelheim’s Pradaxa can be managed

20-11-2011

The European Medicines Agency on Friday providing an update on the safety of independent German drug…

Boehringer IngelheimCardio-vascularEuropePharmaceuticalPradaxaRegulation

Pfizer’s Vyndaqel, first drug to treat rare and fatal disease TTR-FAP, approved in Europe

18-11-2011

Following a positive opinion from an advisory committee in the summer (The Pharma Letter July 23), the…

EuropePfizerPharmaceuticalRare diseasesRegulationtafamidisVyndaqel

AstraZeneca’s thyroid cancer drug Caprelsa gets positive CHMP opinion

18-11-2011

Anglo-Swedish drug major AstraZeneca (LSE: AZN) revealed this morning that its Marketing Authorization…

AstraZenecaCaprelsaEuropeOncologyPharmaceuticalRegulationvandetanib

EU Commission unveils 12 concrete actions against antimicrobial resistance for the next five years

17-11-2011

With about 25,000 patients dying per year in the European Union from infections caused by drug resistant…

Antibiotics and Infectious diseasesEuropePharmaceuticalRegulationResearch

UK’s NICE rejects Eisai’s Halaven for advanced breast cancer

17-11-2011

In a second negative from the UK’s National Institute for Health and Clinical Excellence, in final…

EisaiEuropeHalavenOncologyPharmaceuticalPricingRegulation

Health organizations in USA will act despite political and economic uncertainty, PwC survey finds

16-11-2011

In its annual report on the top health industry issues for the year ahead, PwC's Health Research Institute…

HealthcareNorth AmericaPharmaceuticalRegulationResearch

Increase in US drug recalls and warning caused by manufacturing errors and regulatory non-compliance issues, says GBI

15-11-2011

The numbers of warning letters and drug recalls issued by and reported to the US Food and Drug Administration…

BiotechnologyNorth AmericaPharmaceuticalRegulation

Dyax and Sigma Tau unit pull EU filing on Kalbitor

15-11-2011

USA-based Dyax Corp (Nasdaq: DYAX) says it reached agreement with Defiante Farmaceutica, a unit of privately-held…

Defiante FarmaceuticaDyax CorpEuropeKalbitorPharmaceuticalRare diseasesRegulationSigma Tau

APEC Summit endorses Principles for Industry Codes of Ethics for pharma

14-11-2011

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) said yesterday…

Asia-PacificMarkets & MarketingPharmaceuticalRegulation

Another FDA rejection for Alimera’s DME drug Iluvien

14-11-2011

Shares of US ophthalmic drug develop Alimera Sciences (Nasdaq: ALIM) plunged nearly 73% to $2 on Friday,…

Alimera SciencesIluvienNorth AmericaOphthalmicsPharmaceuticalpSividaRegulation

Turkey issues new unilateral Health Application Announcement

13-11-2011

The Turkey pharmaceutical industry has criticized the new Health Application Announcement (SUT) prepared…

EuropePharmaceuticalRegulation

FDA priority review for Roche/Genentech’s vismodegib for skin cancer

10-11-2011

The US Food and Drug Administration has accepted and filed Swiss drug major Roche (ROG: SIX) subsidiary…

BiotechnologyCurisGenentechNorth AmericaOncologyPharmaceuticalRegulationRochevismodegib

2576 to 2600 of 2631 results

Parexel

Parexel

Back to top